CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+4.1%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.76B
AUM Growth
+$1.76B
(-18%)
Cap. Flow
-$460M
Cap. Flow
% of AUM
-26.22%
Top 10 Holdings %
Top 10 Hldgs %
65.56%
Holding
36
New
3
Increased
6
Reduced
9
Closed
8
Top Buys
| 1 |
McKesson
MCK
|
$99.5M |
| 2 |
Viatris
VTRS
|
$45.8M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$39M |
| 4 |
Puma Biotechnology
PBYI
|
$34.4M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$22M |
Top Sells
| 1 |
GHDX
Genomic Health, Inc.
GHDX
|
$124M |
| 2 |
SHPG
Shire pic
SHPG
|
$110M |
| 3 |
NUVA
NuVasive, Inc.
NUVA
|
$62.5M |
| 4 |
Myriad Genetics
MYGN
|
$56.1M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$53.3M |
Sector Composition
| 1 | Healthcare | 92.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMGI
26
DELISTED
Wright Medical Group Inc
WMGI
| – | – | -1,250,000 | Closed | -$32.5M |
|
|
NUVA
27
DELISTED
NuVasive, Inc.
NUVA
| – | – | -1,200,000 | Closed | -$62.5M |
|
|
CSII
28
DELISTED
Cardiovascular Systems, Inc.
CSII
| – | – | -1,647,677 | Closed | -$53.3M |
|
|
ENDP
29
DELISTED
Endo International plc
ENDP
| – | – | -2,500,000 | Closed | -$23.6M |
|
30
Bristol-Myers Squibb
BMY
$96B
| – | – | 0 | – | – |
|
|
31
Myriad Genetics
MYGN
$593M
| – | – | -1,500,000 | Closed | -$56.1M |
|
32
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
|
MNK
33
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – | -1,900,000 | Closed | -$35.5M |
|
|
GHDX
34
DELISTED
Genomic Health, Inc.
GHDX
| – | – | -2,458,100 | Closed | -$124M |
|
|
CELG
35
DELISTED
Celgene Corp
CELG
| – | – | 0 | – | – |
|
|
SHPG
36
DELISTED
Shire pic
SHPG
| – | – | -650,000 | Closed | -$110M |
|